Peer-reviewedCC BY-NC-NDPharmacological Research
Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023
Related
- Five-flavor Sophora flavescens enteric-coated capsules for ulcerative colitis: ethnopharmacological rationale, pharmacology, clinical evidence, and safety
- Evaluating and leveraging large language models in clinical pharmacology and therapeutics assessment: From exam takers to exam shapers
- Clinical Outcomes Following Mandatory Switching to an Adalimumab Biosimilar in Patients with Psoriasis: A Real-world Single-centre Experience.
- Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
- A Visually Interpretable Histopathology-Based Immune Model Predicts T-effector Biology and Response to Immune checkpoint inhibition in Clear Cell Renal Cell Carcinoma Clinical Trial and Contemporary Real-World Datasets
BibTeX
@article{peh2026immunopharmacology,
title = {{Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023}},
author = {Hong Yong Peh and Danila Gurgone and Pasquale Maffia},
journal = {Pharmacological Research},
year = {2026},
month = oct,
doi = {10.1016/j.phrs.2023.106911},
url = {https://hal.science/hal-05787785v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Immunopharmacology sessions at the 19th World Congress of Basic & Clinical Pharmacology 2023
AU - Hong Yong Peh
AU - Danila Gurgone
AU - Pasquale Maffia
PY - 2026
DA - 2026/10/09
JO - Pharmacological Research
DO - 10.1016/j.phrs.2023.106911
UR - https://hal.science/hal-05787785v1
SN - 1043-6618
SN - 1096-1186
ER -